Which of the following statements is not true regarding α-fetoprotein –
The question asks which statement is not true. Let's think about the options. Since the options aren't provided, maybe I should consider common misconceptions about AFP. For example, AFP is a tumor marker for hepatocellular carcinoma and germ cell tumors. It's also used in prenatal screening for neural tube defects. But what about its role in other cancers? Maybe one of the options incorrectly states it's used for breast cancer or something else.
Another point: AFP levels decrease after birth and are usually undetectable in adults. If an option says that high AFP is normal in adults, that's false. Also, in pregnancy, AFP is part of the triple screen for Down syndrome, but it's more specific for neural tube defects. If an option conflates these, that's a wrong statement.
Wait, the correct answer is the one that's not true. Let's structure the explanation. The core concept is AFP's role as a tumor marker and prenatal screening tool. The correct answer would be an option that incorrectly associates AFP with a condition it doesn't relate to, like breast cancer. The wrong options might include correct uses or other facts. For each wrong option, I need to explain why they're incorrect. The clinical pearl could be remembering that AFP is elevated in HCC and neural tube defects, not in other cancers. The correct answer line should end with the letter and the answer text. Need to make sure the explanation is concise and covers all required sections without exceeding the character limit.
**Core Concept** α-Fetoprotein (AFP) is a glycoprotein synthesized by the fetal liver and yolk sac. In adults, elevated AFP levels are clinically significant as a tumor marker for hepatocellular carcinoma (HCC), germ cell tumors, and in prenatal screening for neural tube defects or Down syndrome. Its role is distinct from other tumor markers like CEA or PSA.
**Why the Correct Answer is Right** The incorrect statement likely claims AFP is elevated in breast cancer. AFP is not a marker for breast malignancy; its primary associations are with HCC, germ cell tumors, and fetal conditions. Elevated AFP in adults is most commonly due to chronic liver disease, HCC, or testicular cancer, not breast cancer.
**Why Each Wrong Option is Incorrect**
**Option A:** If it states AFP is elevated in neural tube defects, this is true. Maternal serum AFP levels rise in open neural tube defects due to fetal leakage into amniotic fluid.
**Option B:** If it claims AFP is produced by fetal yolk sac, this is correct. The yolk sac is a major source of AFP during early gestation.
**Option C:** If it suggests AFP is used in HCC screening, this is accurate. Chronic hepatitis B/C patients are monitored with AFP and ultrasound for HCC detection.
**Clinical Pearl / High-Yield Fact** Remember the "3 Cs" of AFP: **C**arcinoma (HCC, germ cell tumors), **C**ongenital anomalies (neural tube defects), and **C**irrhosis (elevated but not diagnostic